Compound information
- Natural Products
- ZC1294664
- Molecular Formula
- C21H22FN3O4S
- Molecular Weight
- 431.131505404 g/mol
- Structure
-
- IUPAC Name
- N-[3-[4-(4-fluorophenyl)sulfonyl-1,4-diazepane-1-carbonyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C21H22FN3O4S/c1-2-20(26)23-18-6-3-5-16(15-18)21(27)24-11-4-12-25(14-13-24)30(28,29)19-9-7-17(22)8-10-19/h2-3,5-10,15H,1,4,11-14H2,(H,23,26)
- InChI Key
- AZSIIJUKIDZSCS-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cccc(C(=O)N2CCCN(S(=O)(=O)c3ccc(F)cc3)CC2)c1
- Source
- ZINC001135915184
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 86.79 Å2 | LogP | 2.246 |
LogS | -3.736 | LogD | 2.676 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.017 | Pgp substrate | 0.118 |
HIA | 0.965 | F20 % | 0.99 |
F30 % | 0.604 | Caco-2 | -4.556 |
MDCK | -5.005 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.102 | PPB | 91.288 |
VD | 0.638 | Fu | 1.661 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.058 | CYP1A2 substrate | 0.672 |
CYP2A6 substrate | 0.62 | CYP2B6 substrate | 0.628 |
CYP2C19 inhibitor | 0.461 | CYP2C19 substrate | 0.885 |
CYP2C8 substrate | 0.865 | CYP2C9 inhibitor | 0.268 |
CYP2C9 substrate | 0.978 | CYP2D6 inhibitor | 0.044 |
CYP2D6 substrate | 0.968 | CYP2E1 substrate | 0.88 |
CYP3A4 inhibitor | 0.29 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.136 | CL | 0.895 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.046 | Hepatotoxicity | 0.772 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.08 |
FDAMDD | 0.51 | Skin Sensitization | 0.027 |
Carcinogenicity | 0.183 | Eye Corrosion | 0.004 |
Eye Irritation | 0.094 | Respiratory Toxicity | 0.005 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.601 | IGC50 | 3.485 |
LC50FM | -5.378 | LC50DM | -1.136 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.136 | NR-AR-LBD | 0.381 |
NR-AhR | 0.178 | NR-Aromatase | 0.073 |
NR-ER | 0.407 | NR-ER-LBD | 0.456 |
NR-PPAR-gamma | 0.317 | SR-ARE | 0.861 |
SR-ATAD5 | 0.38 | SR-HSE | 0.071 |
SR-MMP | 0.218 | SR-p53 | 0.067 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.